Agreement Signing with GlaxoSmithKline Indonesia

Jakarta, 3 May 2013 - PT Combiphar, a healthcare company and pharmaceutical products manufacturer, is continuing to grow its business in Indonesia through a contract manufacturing agreement with GlaxoSmithKline (GSK) Indonesia to manufacture Scott’s Emulsion. This collaboration was marked through a contract manufacture agreement signing between Mr. Indra J, Santana, Deputy President Director and Lim Soeyantho, Chief Finance Officer of PT Combiphar with Mr. Djagad Prakasa Dwialam, President Director and Mr. Bambang Perwanto, Technical Director of GSK Indonesia. The signing ceremony took place in Combiphar’s office and was witnessed by Mr. Michael Wanandi, President Director of Combiphar and both organization’s respective management.

 

In his address, Mr. Michael Wanandi stated, “As a multinational company, GSK Indonesia has stringent standards and criteria and PT Combiphar’s manufacturing competencies has successfully met them. This adds to PT Combiphar’s manufacturing track record, through our factory in Padalarang, in being able to fulfill high international quality standards”. He added, “Through this strategic cooperation, both organizations can strive to achieve the same ultimate goal of improving the Indonesian people’s health through the availability of quality products.”

Related News
Inspiring People to Live Healthy at COMBIVAGANZA

Follow us and stay up to date on the latest news

SUBSCRIBE

OUR PRODUCTS

Partners

CONTACT US

Senin – Jumat: 08:00 – 17:00
0800-1-800088 (Bebas Pulsa)
0818 06 800088 (sms & whatsapp)
@CombiCareCenter
51F0B55B / COMBICC